Editorial: Women in experimental pharmacology and drug discovery: 2021

Front Pharmacol. 2022 Nov 9:13:1077670. doi: 10.3389/fphar.2022.1077670. eCollection 2022.

Authors

Tea Lanišnik Rižner¹, Csilla Özvegy-Laczka²

Affiliations

¹ Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, University of Ljubljana, Ljubljana, Slovenia.
² Drug Resistance Research Group, Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.

No abstract available

Keywords: Nrf2; SLCO3A1_V3; SLCO4A1; chemerin; high-grade serous ovarian cancer; osteoporosis; osteoprotegerin; premature ovarian failure.

Publication types

Editorial